Labcorp
753 hedge funds and large institutions have $15B invested in Labcorp in 2017 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 268 increasing their positions, 250 reducing their positions, and 44 closing their positions.
130% more first-time investments, than exits
New positions opened: 101 | Existing positions closed: 44
7% more funds holding
Funds holding: 701 → 753 (+52)
6% more capital invested
Capital invested by funds: $14.1B → $15B (+$868M)
7% more repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 250
0.49% more ownership
Funds ownership: 107% → 107.49% (+0.49%)
6% less funds holding in top 10
Funds holding in top 10: 17 → 16 (-1)
17% less call options, than puts
Call options by funds: $36M | Put options by funds: $43.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$99.1M |
| 2 |
BM
Bridger Management
New York
|
+$97.4M |
| 3 |
Morgan Stanley
New York
|
+$57.8M |
| 4 |
Barclays
London,
United Kingdom
|
+$47.1M |
| 5 |
Goldman Sachs
New York
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$72.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$71.4M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$51.6M |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
-$46.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$42.6M |
LH Hedge Fund Activity: Q4 2017 in Review
753 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q4 2017, worth a combined $15B — up 6.1% from $14.1B a quarter earlier.
Buyers outnumbered sellers: 101 funds opened new LH positions and 44 closed out — a net gain of 57 holders — while 268 added to existing stakes and 250 trimmed.
The largest buyer was Boston Partners, adding an estimated $99.1M. The largest seller was HealthCor Management, cutting an estimated $72.6M.
- 753 institutional investors held Labcorp (LH) as of Q4 2017, up from 701 in Q3 2017.
- Funds reported $15B of Labcorp stock for Q4 2017, up 6.1% quarter-over-quarter.
- 101 funds opened new Labcorp positions in Q4 2017 and 44 closed out, a net change of +57 holders.
- The largest Labcorp buyer in Q4 2017 was Boston Partners, an estimated $99.1M added.
- The largest Labcorp seller in Q4 2017 was HealthCor Management, an estimated $72.6M sold.
Based on aggregated 13F filings for Q4 2017.